A rare but life-threatening cardiometabolic problem is known to be associated with serotonin/ dopamine agents that treat psychosis: namely, an association with the sudden occurrence of diabetic ketoacidosis (DKA) or the related condition hyperglycemic hyperosmolar syndrome (HHS). To aid in the prevention of this cardiometabolic problem, the psychopharmacologist's metabolic monitoring tool kit was developed. What does this monitoring tool kit consists of?